Caspase-2 is required for cell death induced by cytoskeletal disruption

被引:100
作者
Ho, L. H. [1 ]
Read, S. H. [1 ]
Dorstyn, L. [1 ]
Lambrusco, L. [1 ]
Kumar, S. [1 ,2 ]
机构
[1] Inst Med & Vet Sci, Div Haematol, Hanson Inst, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia
基金
英国医学研究理事会;
关键词
apoptosis; caspase-2; activation; Bid; Bax; initiator caspase; cytoskeleton;
D O I
10.1038/sj.onc.1211005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Caspase-2 is one of the most conserved caspases, yet its biological function remains a matter of controversy. In the present article we analysed mouse embryonic fibroblasts (MEFs) from caspase-2 knockout mice for their sensitivity to various apoptosis inducing agents. We found that cell death induced by drugs that disrupt cytoskeleton is significantly inhibited in Casp2(-/-) MEFs. These drugs included zoledronic acid, vincristine, cytochalasin D and paclitaxel. We demonstrate that MEFs lacking Casp2 show clonogenic survival following drug treatment, whereas all Casp2(-/-) MEFs die, indicating that caspase-2 is required for apoptosis induced by cytoskeletal disruption. We further found that caspase-2 mediates apoptosis via Piddosome, Bid and Bax activation, and cytochrome c release. In the absence of caspase-2, Bid and Bax activation, and cytochrome c release are significantly delayed following drug treatment. Our data provide strong support for a context-dependent function of caspase-2 in apoptosis.
引用
收藏
页码:3393 / 3404
页数:12
相关论文
共 49 条
[1]   How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? [J].
Antignani, Antonella ;
Youle, Richard J. .
CURRENT OPINION IN CELL BIOLOGY, 2006, 18 (06) :685-689
[2]   The biochemical mechanism of caspase-2 activation [J].
Baliga, BC ;
Read, SH ;
Kumar, S .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (11) :1234-1241
[3]   Defects in regulation of apoptosis in caspase-2-deficient mice [J].
Bergeron, L ;
Perez, GI ;
Macdonald, G ;
Shi, LF ;
Sun, Y ;
Jurisicova, A ;
Varmuza, S ;
Latham, KE ;
Flaws, JA ;
Salter, JCM ;
Hara, H ;
Moskowitz, MA ;
Li, E ;
Greenberg, A ;
Tilly, JL ;
Yuan, JY .
GENES & DEVELOPMENT, 1998, 12 (09) :1304-1314
[4]   Microtubule-targeted anticancer agents and apoptosis [J].
Bhalla, KN .
ONCOGENE, 2003, 22 (56) :9075-9086
[5]   Caspase-2-induced apoptosis requires bid cleavage: A physiological role for bid in heat shock-induced death [J].
Bonzon, C ;
Bouchier-Hayes, L ;
Pagliari, LJ ;
Green, DR ;
Newmeyer, DD .
MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (05) :2150-2157
[6]   Dimerization and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions [J].
Butt, AJ ;
Harvey, NL ;
Parasivam, G ;
Kumar, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :6763-6768
[7]   Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain [J].
Colussi, PA ;
Harvey, NL ;
Shearwin-Whyatt, LM ;
Kumar, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26566-26570
[8]   A decade of caspases [J].
Degterev, A ;
Boyce, M ;
Yuan, JY .
ONCOGENE, 2003, 22 (53) :8543-8567
[9]   DRONC, an ecdysone-inducible Drosophila caspase [J].
Dorstyn, L ;
Colussi, PA ;
Quinn, LM ;
Richardson, H ;
Kumar, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4307-4312
[10]   Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die [J].
Ekert, PG ;
Read, SH ;
Silke, J ;
Marsden, VS ;
Kaufmann, H ;
Hawkins, CJ ;
Gerl, R ;
Kumar, S ;
Vaux, DL .
JOURNAL OF CELL BIOLOGY, 2004, 165 (06) :835-842